UniProt ID | BIRC2_MOUSE | |
---|---|---|
UniProt AC | Q62210 | |
Protein Name | Baculoviral IAP repeat-containing protein 2 | |
Gene Name | Birc2 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 612 | |
Subcellular Localization | Cytoplasm. Nucleus. Agents that induce either the extrinsic or intrinsic apoptotic pathways promote its redistribution from the nuclear compartment to the cytoplasmic compartment. Associated with the midbody in telophase cells, and found diffusely in | |
Protein Description | Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, mitogenic kinase signaling, and cell proliferation, as well as cell invasion and metastasis. Acts as an E3 ubiquitin-protein ligase regulating NF-kappa-B signaling and regulates both canonical and non-canonical NF-kappa-B signaling by acting in opposite directions: acts as a positive regulator of the canonical pathway and suppresses constitutive activation of non-canonical NF-kappa-B signaling. The target proteins for its E3 ubiquitin-protein ligase activity include: RIPK1, RIPK2, RIPK3, RIPK4, CASP3, CASP7, CASP8, TRAF2, DIABLO/SMAC, MAP3K14/NIK, MAP3K5/ASK1, IKBKG/NEMO, IKBKE and MXD1/MAD1. Can also function as an E3 ubiquitin-protein ligase of the NEDD8 conjugation pathway, targeting effector caspases for neddylation and inactivation. Acts as an important regulator of innate immune signaling via regulation of Toll-like receptors (TLRs), Nodlike receptors (NLRs) and RIG-I like receptors (RLRs), collectively referred to as pattern recognition receptors (PRRs). Protects cells from spontaneous formation of the ripoptosome, a large multi-protein complex that has the capability to kill cancer cells in a caspase-dependent and caspase-independent manner. Suppresses ripoptosome formation by ubiquitinating RIPK1 and CASP8. Can stimulate the transcriptional activity of E2F1. Plays a role in the modulation of the cell cycle.. | |
Protein Sequence | MDKTVSQRLGQGTLHQKLKRIMEKSTILSNWTKESEEKMKFDFSCELYRMSTYSAFPRGVPVSERSLARAGFYYTGVNDKVKCFCCGLMLDNWKQGDSPVEKHRQFYPSCSFVQTLLSASLQSPSKNMSPVKSRFAHSSPLERGGIHSNLCSSPLNSRAVEDFSSRMDPCSYAMSTEEARFLTYSMWPLSFLSPAELARAGFYYIGPGDRVACFACGGKLSNWEPKDDAMSEHRRHFPHCPFLENTSETQRFSISNLSMQTHSARLRTFLYWPPSVPVQPEQLASAGFYYVDRNDDVKCFCCDGGLRCWEPGDDPWIEHAKWFPRCEFLIRMKGQEFVDEIQARYPHLLEQLLSTSDTPGEENADPTETVVHFGPGESSEDVVMMSTPVVKAALEMGFSRSLVRQTVQRQILATGENYRTVNDIVSVLLNAEDERREEEKERQTEEMASGDLSLIRKNRMALFQQLTHVLPILDNLLEASVITKQEHDIIRQKTQIPLQARELIDTVLVKGNAAANIFKNSLKEIDSTLYENLFVEKNMKYIPTEDVSGLSLEEQLRRLQEERTCKVCMDREVSIVFIPCGHLVVCQECAPSLRKCPICRGTIKGTVRTFLS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
82 | Ubiquitination | TGVNDKVKCFCCGLM CCCCCCEEEEECCCC | 27.60 | - | |
94 | Ubiquitination | GLMLDNWKQGDSPVE CCCCCCCCCCCCCHH | 51.13 | - | |
115 | Phosphorylation | PSCSFVQTLLSASLQ CCCHHHHHHHHHHCC | 25.10 | 22871156 | |
118 | Phosphorylation | SFVQTLLSASLQSPS HHHHHHHHHHCCCCC | 20.94 | 22871156 | |
120 | Phosphorylation | VQTLLSASLQSPSKN HHHHHHHHCCCCCCC | 24.46 | 26643407 | |
123 | Phosphorylation | LLSASLQSPSKNMSP HHHHHCCCCCCCCCC | 36.11 | 26745281 | |
125 | Phosphorylation | SASLQSPSKNMSPVK HHHCCCCCCCCCCCH | 41.74 | 26643407 | |
129 | Phosphorylation | QSPSKNMSPVKSRFA CCCCCCCCCCHHHCC | 35.62 | 22871156 | |
138 | Phosphorylation | VKSRFAHSSPLERGG CHHHCCCCCCCCCCC | 30.16 | 26643407 | |
139 | Phosphorylation | KSRFAHSSPLERGGI HHHCCCCCCCCCCCC | 24.52 | 26643407 | |
143 | Methylation | AHSSPLERGGIHSNL CCCCCCCCCCCCCCC | 57.21 | 24129315 | |
148 | Phosphorylation | LERGGIHSNLCSSPL CCCCCCCCCCCCCCC | 29.58 | 29472430 | |
152 | Phosphorylation | GIHSNLCSSPLNSRA CCCCCCCCCCCCHHH | 37.85 | 25266776 | |
153 | Phosphorylation | IHSNLCSSPLNSRAV CCCCCCCCCCCHHHH | 32.20 | 26824392 | |
157 | Phosphorylation | LCSSPLNSRAVEDFS CCCCCCCHHHHHHHH | 29.33 | 29472430 | |
399 | Phosphorylation | AALEMGFSRSLVRQT HHHHCCCCHHHHHHH | 18.41 | 25159016 | |
401 | Phosphorylation | LEMGFSRSLVRQTVQ HHCCCCHHHHHHHHH | 29.98 | 25159016 | |
527 | Phosphorylation | NSLKEIDSTLYENLF HHHHHHHHHHHHHHH | 26.44 | 28285833 | |
551 | Phosphorylation | TEDVSGLSLEEQLRR CCCCCCCCHHHHHHH | 36.94 | 26824392 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BIRC2_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BIRC2_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
GLMN_MOUSE | Glmn | physical | 29191979 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...